Treatment of systemic sclerosis-associated interstitial lung disease: Lessons from clinical trials.

Roofeh, David; Distler, Oliver; Allanore, Yannick; Denton, Christopher P; Khanna, Dinesh

Roofeh, David; Distler, Oliver; Allanore, Yannick; Denton, Christopher P; Khanna, Dinesh.

Afiliação

Roofeh D; Scleroderma Program, University of Michigan, Ann Arbor, MI, USA.
Distler O; Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
Allanore Y; Department of Rheumatology A, Cochin Hospital, Paris Descartes University, Paris, France.
Denton CP; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital, London, UK.
Khanna D; Scleroderma Program, University of Michigan, Ann Arbor, MI, USA.

J Scleroderma Relat Disord ; 5(2 Suppl): 61-71, 2020 Mar.

Article em En | MEDLINE | ID: mdl-35382226

Palavras-chave

Systemic sclerosis; clinical trials; interstitial lung disease; management; treatment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Risk_factors_studies Idioma: En Revista: J Scleroderma Relat Disord Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google